The heteroatom possessing bis-allylpalladium analogs were reacted by extending the reaction of bis-allylation. The 2-alkynylisocyanobenzenes, allyl methyl carbonate, and trimethylsilyl azide were reacted by palladium-catalyzed three-component coupling reaction to afford good yields of N-cyanoindoles (Scheme 17).[84] The reaction proceeded through the formation of allylpalladium azide, and subsequently the allylpalladium intermediate was produced by the insertion of divalent carbon of isocyanide into the NPd bond of allylpalladium azide. The allylpalladium intermediate eliminated the nitrogen to form the bis-allylpalladium analog (3-allyl)(3-cyanamido)palladium complex.
Barluenga et al.[87] reported a domino reaction of o-halobenzene or o-dihaloarenes sulfonates (o-chlorononaflates were the best substrates) with imines for the preparation of indoles through a selective palladium-catalyzed imine C-arylation followed by an intramolecular C–N bond formation reaction with palladium catalyst (Scheme 19).
Palladium catalyst was utilized for the formation of these precursors in concert with cyclization as well as simply mediated the formation of C–N bonds. Barluenga demonstrated the one example where palladium catalyst was used for the formation of two separate bonds; first through arylation of the azaallylic anion of imine the C–C bond was formed and then C-N bond was formed catalytically.[31b,44]
The reaction showed wide scope with o-dibromobenzene. The alkyl, aryl, and vinyl substituents were introduced at different positions of pyrrole ring of the indole. The regioselective preparation of indoles substituted in the benzene ring was conducted, with the advantage of different reactivities of Cl, Br, and I in oxidative addition reactions, by reacting o-dihalobenzene derivatives with two different halogens
(Scheme 20).[44,89]
A more general approach was developed to influence the regioselectivity using catalyst which affected the alkyne insertion step. Konno[90] found that the bulkier P(o-tol)3 ligand favored the formation of 3-CF3 substituted products whereas PPh3 preferred the generation of 2-CF3 substituted indoles (Scheme 21).
The precursors for Heck cyclization were generated by an efficient palladium catalyzed C–N bond forming reactions. Jorgensen[91] has shown that how the tandem C–N bond formation (with the aryl-iodide)/Heck cyclization cascade of starting material and allyl amines in the presence of palladium catalyst can afford one pot synthetic protocol for the formation of indoles (Scheme 23).[92,93] After screening, it was found that the dppf ligand in concert with Pd2dba3 was optimum catalyst for these two steps and it afforded a pathway for the synthesis of a variety of 3-substituted indoles.[31b]
The 2-haloanilines were coupled with vinylbromides in this method. Barluenga[94] has demonstrated that depending upon the used ligand, this method formed either indoles or simple imines. The indole was synthesized exclusively with bulky phosphines (Scheme 24). The o-bromoanilines were reacted with alkenyl halides for the synthesis of indoles through a domino process through an alkenyl amination followed by an intramolecular Heck reaction. The alkenyl halides reacted in the order as follows: alkenyl bromides > aryl bromides > alkenyl chlorides > aryl chlorides. The combination of 2 dicyclohexylphosphino-N,N-dimethylaminobiphenyl (DavePhos), Pd2(dba)3, and t-BuONa at 100 C in toluene afforded the best results. The reaction occurred with alkyl, aryl, and functionalized substituents in both starting substrates. The indoles were only synthesized with 1-substituted-2-bromoalkenes by cyclization of N-substituted o-bromoanilines (which provided N-substituted indoles). A catalytic combination of Pd2(dba)3 and XPhos was needed for employing this strategy to o-chloroanilines.[31b,44]
Ethyl 3-(o-trifluoroacetamidoaryl)-1-propargylic carbonates were reacted with primary or secondary amines to form the N-unsubstituted indole-2-acetamides with the help of 1,10-bis(dimethylphosphino)ferrocene (dppf), Pd2(dba)3, and CO at 80 C in THF (Scheme 25).[95,96] The reaction was employed for the preparation of N-unsubstituted indole 2-acetic acid methyl esters [dppf, Pd2(dba)3, MeOH/THF, CO, 24 h, 80 C].[44]
The stereoselectivity, which afforded congested quaternary carbon centers in the palladium-catalyzed intramolecular Heck cyclizations, can be inverted with a silver salt (Scheme 30).[101] The coordination of angular vinyl group during the insertion step has shown high selectivity in this case.[102]
The o-ethynyltrifluoroacetanilide was used for the synthesis of 2-unsubstituted 3-aryl indoles in this process.[103] Much more optimization was required in the reaction of aryl iodides with anilide which possessed an o-terminal alkyne moiety, because under the standard conditions developed for o-alkynyltrifluoroacetanilides, coupling derivatives[104,105] were formed in a significant side reaction. Indeed, under a variety of reaction conditions coupling derivatives were obtained in the presence of a number of phosphine ligands. The coupling derivative was observed in 83% yield from the reaction of o-ethynyltrifluoroacetanilide with p-iodoacetophenone [Pd2(dba)3, 60 C, THF, 7 h] using tris(p-chlorophenyl)phosphine. One more significant side reaction was observed in which 2-unsubstituted 3-aryl indoles were formed with the nucleophilic attack of oxygen at the “internal” carbon of the activated C,C triple bond. The N-/O-cyclization ratio was influenced strongly by both the nature of the catalyst and the solvent. The use of DMSO as the solvent, Pd2(dba)3 as the palladium(0) source, and K2CO3 as the base in the absence of phosphine ligands afforded best results (Scheme 31). Cesium carbonate was also used successfully. The indole was obtained in 80% yield when o-ethynyltrifluoroacetanilide was reacted under same reaction conditions omitting aryl iodides.[44,49b]
one of the biaryl monophosphines which increased the rate of the oxidative addition of aryl chlorides to Pd(0) species.[106–108] One of the major problems realized in this indole synthesis was solved using this ligand with relatively unreactive precursors of organopalladium complexes, like, the competitive formation of simple 2-substituted indoles, the formation of which does not involve the aryl halide partner.[44,65,67–69]
Metal-catalyzed amide C-arylations (Scheme 34) effectively afford the expected oxindole products.[26,109] This oxindole ring can be formed when aromatic substrates contain a halogen atom situated ortho to a moiety containing a reactive functional group. For example, intramolecular radical cyclizations and Heck cyclizations have been used to form the C3-C4 bond of the oxindole nucleus (Scheme 35).[110–116]
Grigg and coworkers[117] described the in situ Pd-catalyzed preparation of tributylstannyl-1,2-carbodialkylidene through one-pot protocol from 1,6-diynes and TBTH which was then further coupled with iodobenzene possessing a proximate alkene group and anion capture to provide the good yields of targeted indoline derivatives (Scheme 36).[91]
The alkyl, aryl, and functionalized geminal bromoalkenes participated in an indolization reaction. A new optimization was done with o-chloroanilines. When XPhos was used as a supporting ligand then only the tandem process was achieved. The indoles were synthesized with similar yields to those observed with o-bromoanilines under these conditions[52,118] (Scheme 37).
The starting substrates N-(o-halophenyl)allenamides were utilized in a new protocol for the formation of 3-substituted, 2-unsubstituted, and 2,3-disubstituted indoles through an intramolecular carbopalladation/anion capture domino reaction with boron nucleophiles. The 2-silylindoles were synthesized when an appropriate silicon group was selectively introduced to the a-position of the allenamide functionality. The formed 2-silylindoles were substrates for further functionalization at the C-2 position (Scheme 39). Fuwa and Sasaki[123a] described this approach based on the intramolecular carbopalladation/cyclization-anion capture protocol for the synthesis of 2,3-disubstituted indole derivatives. The palladium p-allyl intermediate was formed from allenamides which contain a substituent at the a-position through a facile carbopalladation/cyclization. The formed palladium p-allyl intermediate was then cross-coupled with a number of orgnanoboron species to provide various 2,3-disubstituted indoles.[44,123b]
Precedent for competitive oxidative amination in a carboamination reaction was seen previously by the Wolfe group.[124,125] For example, as shown in Scheme 40, in the reaction of N-benzyl-2-allylaniline with 4-bromotoluene to form an indoline, the oxidative amination product N-benzyl-2-methylindole was formed as a byproduct. Furthermore, oxidative amination products can even be preferentially formed over carboamination products with proper ligand choice.
The nitrogen behaved as an ambivalent atom in this operation. As a nucleophile, it intervened in the N-allylation step and in the cyclization step as a leaving group which favored the synthesis of a p-allylpalladium complex. With a number of o-alkynyltrifluoroacetanilides and allylic carbonates, these methods afforded good results. In one of the method, o-ethynyltrifluoroacetanilide was utilized to provide 2-unsubstituted 3-allylindoles in allowable yields. The substituent present on the central carbon atom of the allylic compound was tolerated, whereas the cyclization reaction was hampered when
the sterically encumbered substituents were present at one end of the alkyne moiety or the substitution was available at both termini of the allylic system. The most challenging situation to the regiochemistry of the new C-C bond was faced when there were small steric differences between the two allylic termini. The best results were observed with tris(2,4,6-trimethoxyphenyl)-phosphine (ttmpp) and the reaction afforded remarkable regioselectivity and the less substituted terminus of the allylic system bears the indole unit almost exclusively. Some loss of olefin geometry was observed in this process[44,145](Scheme 43).
Previously in the Wolfe group,[83,146,147] the Pd-catalyzed carboamination of c-(N-arylamino) alkenes and c-(N-Boc-amino) alkenes to afford substituted pyrrolidines has been demonstrated. For example, reaction of a 1-substituted c-(N-arylamino) alkene with 4-bromoanisole gave cis-2,5-disubstituted pyrrolidine and a regioisomer in good yield and diastereoselectivity as a 10:1 mixture of regioisomers (Scheme 44).
Mercury, (dichloromethyl)phenyl-
Catalog No.:AG0005EV MDL No.:
MF:C7H6Cl2Hg MW:361.6185
|
Benzenemethanamine, 2-iodo-N,N-dimethyl-
Catalog No.:AG0005EU MDL No.:
MF:C9H12IN MW:261.1028
|
Magnesium, butylethoxy-
Catalog No.:AG0005ET MDL No.:
MF:C6H14MgO MW:126.4798
|
Disiloxane, 1,5-bis(1,1-dimethylethyl)-2,2,4,4-tetramethyl-
Catalog No.:AG0005ES MDL No.:
MF: MW:
|
Silane, triethyloctyl-
Catalog No.:AG0005ER MDL No.:
MF:C14H32Si MW:228.4894
|
Phosphonic acid, P-[[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]methyl]-, monobutyl ester, zinc salt (2:1)
Catalog No.:AG0005EQ MDL No.:
MF:C38H64O8P2Zn MW:776.2375
|
Phenol, 4-(2-chloroethyl)-2,6-bis(1,1-dimethylethyl)-
Catalog No.:AG0005FK MDL No.:
MF:C16H25ClO MW:268.8221
|
2-Quinoxalineacetic acid, 3-chloro-α-cyano-, methyl ester
Catalog No.:AG0005FJ MDL No.:MFCD07345521
MF:C12H8ClN3O2 MW:261.6638
|
3-Pyridinecarbonitrile, 2-chloro-6-methyl-5-phenyl-
Catalog No.:AG0005FI MDL No.:MFCD00231559
MF:C13H9ClN2 MW:228.6770
|
3-Pyridinecarboxylic acid, 6-methyl-5-phenyl-, methyl ester
Catalog No.:AG0005FH MDL No.:
MF:C14H13NO2 MW:227.2585
|
3-Pyridinecarbonitrile, 6-methyl-5-phenyl-
Catalog No.:AG0005FG MDL No.:
MF:C13H10N2 MW:194.2319
|
L-Glutamic acid, N-[4-[[(2-amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl]-2-propynylamino]benzoyl]- (9CI)
Catalog No.:AG0005FF MDL No.:
MF:C22H21N7O6 MW:479.4454
|
4(1H)-Pyridinone, 3-(4-chlorophenyl)-5,6-dihydro-1-(phenylmethyl)-
Catalog No.:AG0005F4 MDL No.:
MF:C18H16ClNO MW:297.7787
|
4(1H)-Pyridinone, 5,6-dihydro-1-(phenylmethyl)-3-(3,4,5-trimethoxyphenyl)-
Catalog No.:AG0005F3 MDL No.:
MF:C21H23NO4 MW:353.4116
|
4(1H)-Pyridinone, 5,6-dihydro-3-(3-hydroxyphenyl)-1-(phenylmethyl)-
Catalog No.:AG0005F2 MDL No.:
MF:C18H17NO2 MW:279.3331
|
2-Pyrazinecarboxylic acid, 5-(1-piperidinyl)-, methyl ester
Catalog No.:AG0005F1 MDL No.:
MF:C11H15N3O2 MW:221.2557
|
2-Pyrazinecarboxylic acid, 5-(4-morpholinyl)-, methyl ester
Catalog No.:AG0005F0 MDL No.:
MF:C10H13N3O3 MW:223.2285
|
4-Morpholinemethanaminium, α-fluoro-N,N-dimethyl-, hexafluorophosphate(1-) (1:1)
Catalog No.:AG0005EZ MDL No.:MFCD24368601
MF: MW:
|
1-Piperazinecarboxylic acid, 4-[(2S)-2-aminopropyl]-, 1,1-dimethylethyl ester
Catalog No.:AG0005EY MDL No.:MFCD18249855
MF:C12H25N3O2 MW:243.3458
|
Phenol, 4-iodo-3-(1-methylethyl)-
Catalog No.:AG0005EX MDL No.:MFCD11101057
MF:C9H11IO MW:262.0875
|
1H-Indole-2,3-dione, 5,7-dimethyl-1-(phenylmethyl)-
Catalog No.:AG0005EW MDL No.:MFCD11111099
MF:C17H15NO2 MW:265.3065
|
4-Dibenzofuranol, 4-acetate
Catalog No.:AG0005FE MDL No.:
MF:C14H10O3 MW:226.2274
|
Benzenesulfonic acid, dibromo-
Catalog No.:AG0005FD MDL No.:
MF:C6H4Br2O3S MW:315.9672
|
2H-Pyran, tetrahydro-4-(methoxymethylene)-
Catalog No.:AG0005FC MDL No.:
MF:C7H12O2 MW:128.1690
|
1-Butanol, 2-methyl-4-[(tetrahydro-2H-pyran-2-yl)oxy]-
Catalog No.:AG0005FB MDL No.:
MF:C10H20O3 MW:188.2640
|
4-Thiazolecarboxylic acid, 2-methyl-, hydrazide
Catalog No.:AG0005FA MDL No.:MFCD00662677
MF:C5H7N3OS MW:157.1936
|
Ethanone, 1-[3-methyl-6-(trifluoromethyl)-4H-1,4-benzothiazin-2-yl]-
Catalog No.:AG0005F9 MDL No.:
MF:C12H10F3NOS MW:273.2741
|
Pyrrolidine, 1-(phenylmethyl)-3-(phenylsulfonyl)-
Catalog No.:AG0005F8 MDL No.:
MF:C17H19NO2S MW:301.4033
|
4-Piperidinol, 1-(diphenylmethyl)-
Catalog No.:AG0005F7 MDL No.:
MF:C18H21NO MW:267.3654
|
Piperidine, 4-[(4-chlorophenyl)thio]-
Catalog No.:AG0005F6 MDL No.:MFCD04115009
MF:C11H14ClNS MW:227.7536
|
Piperidine, 4-[(4-chlorophenyl)sulfonyl]-, hydrochloride (1:1)
Catalog No.:AG0005F5 MDL No.:MFCD04115824
MF:C11H15Cl2NO2S MW:296.2133
|
1H-Indazole, 7-fluoro-3-methyl-
Catalog No.:AG0005FO MDL No.:MFCD17010089
MF:C8H7FN2 MW:150.1530
|
1H-Indazole, 6,7-difluoro-3-methyl-
Catalog No.:AG0005FN MDL No.:MFCD28041003
MF:C8H6F2N2 MW:168.1434
|
1H-Indazole, 4,6-difluoro-3-methyl-
Catalog No.:AG0005FM MDL No.:
MF:C8H6F2N2 MW:168.1434
|
2-Thiophenecarboxylic acid, 3-bromo-5-phenyl-
Catalog No.:AG0005FL MDL No.:
MF:C11H7BrO2S MW:283.1411
|
Pyrrolidine, 3-(phenylsulfonyl)-
Catalog No.:AG0005FP MDL No.:MFCD08445575
MF:C10H13NO2S MW:211.2807
|
3-Pyridinecarbonitrile, 2,6-dichloro-5-phenyl-
Catalog No.:AG0005G9 MDL No.:MFCD00235086
MF:C12H6Cl2N2 MW:249.0954
|
3-Pyridinecarboxylic acid, 1,2-dihydro-2-oxo-5-phenyl-
Catalog No.:AG0005G8 MDL No.:MFCD00835053
MF:C12H9NO3 MW:215.2048
|
3-Pyridinecarbonitrile, 2-chloro-5-phenyl-
Catalog No.:AG0005G7 MDL No.:MFCD00231610
MF:C12H7ClN2 MW:214.6504
|
3-Pyridinecarbonitrile, 5-phenyl-
Catalog No.:AG0005G6 MDL No.:MFCD11044310
MF:C12H8N2 MW:180.2053
|
3-Pyridinecarboxylic acid, 5-phenyl-
Catalog No.:AG0005G5 MDL No.:MFCD03086176
MF:C12H9NO2 MW:199.2054
|
3-Pyridinecarboxylic acid, 5-phenyl-, methyl ester
Catalog No.:AG0005G4 MDL No.:MFCD06802742
MF:C13H11NO2 MW:213.2319
|
Pyridine, 4-chloro-2-(chloromethyl)-
Catalog No.:AG0005G3 MDL No.:MFCD07774098
MF:C6H5Cl2N MW:162.0166
|
3-Pyridinecarboxylic acid, 6-(chloromethyl)-, ethyl ester
Catalog No.:AG0005G2 MDL No.:MFCD10697587
MF:C9H10ClNO2 MW:199.6342
|
Pyridine, 5-chloro-2-(chloromethyl)-
Catalog No.:AG0005G1 MDL No.:MFCD10697588
MF:C6H5Cl2N MW:162.0166
|
3-Pyridinecarboxylic acid, 4-chloro-
Catalog No.:AG0005G0 MDL No.:MFCD00128860
MF:C6H4ClNO2 MW:157.5545
|
3-Pyridinecarboxylic acid, 4-methoxy-
Catalog No.:AG0005FZ MDL No.:MFCD04115724
MF:C7H7NO3 MW:153.1354
|
3-Pyridinecarboxylic acid, 4-methoxy-, methyl ester
Catalog No.:AG0005FY MDL No.:MFCD09864940
MF:C8H9NO3 MW:167.1620
|
3-Pyridinecarboxylic acid, 1,4-dihydro-4-oxo-, ethyl ester
Catalog No.:AG0005FX MDL No.:
MF:C8H9NO3 MW:167.1620
|
Plumbanecarbonitrile, triphenyl-
Catalog No.:AG0005FW MDL No.:
MF:C19H15NPb MW:464.5291
|
Germane, chlorodiethyl-
Catalog No.:AG0005FV MDL No.:
MF:C4H11ClGe MW:167.2231
|
Germane, dibromobis(2,3,4,5,6-pentafluorophenyl)-
Catalog No.:AG0005FU MDL No.:
MF:C12Br2F10Ge MW:566.5604
|
1,2-Oxaphospholan-3-ol, 2-methoxy-3-methyl-5-(2-nitrophenyl)-, 2-oxide
Catalog No.:AG0005FT MDL No.:
MF:C11H14NO6P MW:287.2057
|
Phosphine, bis(3-methylphenyl)-
Catalog No.:AG0005FS MDL No.:
MF:C14H15P MW:214.2427
|
Phosphine, bis(2-methoxyphenyl)-
Catalog No.:AG0005FR MDL No.:
MF:C14H15O2P MW:246.2415
|
Silane, pentyl-
Catalog No.:AG0005FQ MDL No.:
MF:C5H14Si MW:102.2502
|
D-Valine, N-[N-(phenylacetyl)-L-cysteinyl]- (9CI)
Catalog No.:AG0005GX MDL No.:
MF:C16H22N2O4S MW:338.4219
|
L-Argininamide, N-[(2Z)-3-carboxy-1-oxo-2-propenyl]-L-phenylalanyl- (9CI)
Catalog No.:AG0005GW MDL No.:
MF:C19H26N6O5 MW:418.4469
|
3H-Pyrazol-3-one, 2,4-dihydro-5-methyl-2-(2-methylbenzoyl)-
Catalog No.:AG0005GV MDL No.:
MF:C12H12N2O2 MW:216.2359
|
Quinoline, 2-(2H-tetrazol-5-yl)-
Catalog No.:AG0005GU MDL No.:
MF:C10H7N5 MW:197.1961
|
L-Serine, N-[(1,1-dimethylethoxy)carbonyl]-N-methyl-
Catalog No.:AG0005GT MDL No.:MFCD00037249
MF:C9H17NO5 MW:219.2350
|
Benzamide, 4-(hexyloxy)-
Catalog No.:AG0005GS MDL No.:
MF:C13H19NO2 MW:221.2955
|
1H-Imidazole-2-carboxamide, 4-[[[4-[[2-[(aminoiminomethyl)amino]acetyl]amino]-1-methyl-1H-pyrrol-2-yl]carbonyl]amino]-N-(3-amino-3-iminopropyl)-1-methyl-, sulfate (1:1)
Catalog No.:AG0005GR MDL No.:
MF:C17H27N11O7S MW:529.5308
|
1H-Imidazole-2-carboxamide, 4-[[2-[(aminoiminomethyl)amino]acetyl]amino]-N-[2-[[(3-amino-3-iminopropyl)amino]carbonyl]-1-methyl-1H-imidazol-4-yl]-1-methyl-, sulfate (1:1)
Catalog No.:AG0005GQ MDL No.:
MF:C16H26N12O7S MW:530.5188
|
1H-Imidazole-2-carboxamide, 4-[[[4-[[2-[(aminoiminomethyl)amino]acetyl]amino]-1-methyl-1H-imidazol-2-yl]carbonyl]amino]-N-[2-[[(3-amino-3-iminopropyl)amino]carbonyl]-1-methyl-1H-imidazol-4-yl]-1-methyl-, hydrochloride (1:2)
Catalog No.:AG0005GP MDL No.:
MF:C21H31Cl2N15O4 MW:628.4749
|
Ethanaminium, 2-[[5-[[[5-[[(3-amino-3-iminopropyl)amino]carbonyl]-1-methyl-1H-pyrrol-3-yl]amino]carbonyl]-1-methyl-1H-pyrrol-3-yl]amino]-N,N,N-trimethyl-2-oxo-, sulfate (1:1)
Catalog No.:AG0005GO MDL No.:
MF:C20H32N8O7S MW:528.5825
|
Silacyclohexane, 1,1,3-trimethyl-
Catalog No.:AG0005GN MDL No.:
MF:C8H18Si MW:142.3140
|
Boronic acid, (1,1-dichloroethyl)-, dimethyl ester (9CI)
Catalog No.:AG0005GM MDL No.:
MF:C4H9BCl2O2 MW:170.8301
|
5(1H)-Indolizinone, 2,3-dihydro-
Catalog No.:AG0005GL MDL No.:MFCD19704726
MF:C8H9NO MW:135.1632
|
1-Cyclobutene-1,2-dicarboxylic acid, 3-ethenyl-, 1,2-dimethyl ester
Catalog No.:AG0005GK MDL No.:
MF:C10H12O4 MW:196.1999
|
Isoxazole, 4-bromo-3-phenyl-
Catalog No.:AG0005GJ MDL No.:MFCD27940886
MF:C9H6BrNO MW:224.0540
|
1H-Indole-3-carboxylic acid, 6-bromo-
Catalog No.:AG0005GI MDL No.:MFCD05664008
MF:C9H6BrNO2 MW:240.0534
|
4-Isoquinolinol, 3-chloro-
Catalog No.:AG0005GH MDL No.:MFCD11846288
MF:C9H6ClNO MW:179.6030
|
4(1H)-Quinolinone, 5-chloro-
Catalog No.:AG0005GG MDL No.:
MF:C9H6ClNO MW:179.6030
|
Bicyclo[2.2.1]heptane-2-carboxylic acid, 2-chloro-
Catalog No.:AG0005GF MDL No.:
MF:C8H11ClO2 MW:174.6247
|
2,4(1H,3H)-Pyrimidinedione, 1,3-diethyl-6-(methylamino)-
Catalog No.:AG0005GE MDL No.:
MF:C9H15N3O2 MW:197.2343
|
Isoquinoline, 1,2,3,4-tetrahydro-6,7-dimethoxy-1-propyl-, hydrochloride (1:1)
Catalog No.:AG0005GD MDL No.:
MF:C14H22ClNO2 MW:271.7830
|
Ethanone, 1-(4-chloro-2,6-difluorophenyl)-
Catalog No.:AG0005GC MDL No.:MFCD09832259
MF:C8H5ClF2O MW:190.5745
|
Benzenamine, 2-chloro-6-fluoro-3-methoxy-
Catalog No.:AG0005GB MDL No.:MFCD09832265
MF:C7H7ClFNO MW:175.5880
|
Phenol, 2-chloro-6-fluoro-3-methoxy-
Catalog No.:AG0005GA MDL No.:MFCD09832266
MF:C7H6ClFO2 MW:176.5727
|
Benzeneacetic acid, 6-chloro-2-fluoro-3-methoxy-
Catalog No.:AG0005HM MDL No.:MFCD09832273
MF:C9H8ClFO3 MW:218.6094
|
Benzenamine, 2,3-dichloro-6-(trifluoromethyl)-
Catalog No.:AG0005HL MDL No.:MFCD09832277
MF:C7H4Cl2F3N MW:230.0146
|
Benzenepropanoic acid, 2-methyl-3-(trifluoromethyl)-
Catalog No.:AG0005HK MDL No.:MFCD09832282
MF:C11H11F3O2 MW:232.1990
|
Phenol, 2-methyl-5-(trifluoromethyl)-
Catalog No.:AG0005HJ MDL No.:MFCD09832287
MF:C8H7F3O MW:176.1358
|
Benzoic acid, 3,4-difluoro-5-methyl-
Catalog No.:AG0005HI MDL No.:MFCD09832332
MF:C8H6F2O2 MW:172.1288
|
Benzaldehyde, 3,4-difluoro-5-methyl-
Catalog No.:AG0005HH MDL No.:MFCD09832333
MF:C8H6F2O MW:156.1294
|
Benzeneacetic acid, 2-methoxy-6-(trifluoromethyl)-
Catalog No.:AG0005HG MDL No.:MFCD09832328
MF:C10H9F3O3 MW:234.1719
|
Benzene, 1-(bromomethyl)-2-(difluoromethoxy)-4-fluoro-
Catalog No.:AG0005HF MDL No.:MFCD09832363
MF:C8H6BrF3O MW:255.0318
|
Benzaldehyde, 4-ethoxy-2,6-difluoro-
Catalog No.:AG0005HE MDL No.:MFCD09258695
MF:C9H8F2O2 MW:186.1554
|
Benzene, 2-(bromomethyl)-5-ethoxy-1,3-difluoro-
Catalog No.:AG0005HD MDL No.:MFCD09258697
MF:C9H9BrF2O MW:251.0680
|
Benzenepropanoic acid, 3-fluoro-5-methyl-
Catalog No.:AG0005HC MDL No.:MFCD09832369
MF:C10H11FO2 MW:182.1915
|
Benzeneacetic acid, 4-ethoxy-2,3-difluoro-
Catalog No.:AG0005HB MDL No.:MFCD09258707
MF:C10H10F2O3 MW:216.1814
|
Benzenamine, 3-fluoro-4-(trifluoromethoxy)-
Catalog No.:AG0005HA MDL No.:MFCD09832383
MF:C7H5F4NO MW:195.1143
|
Benzenamine, 4,5-difluoro-2-methoxy-
Catalog No.:AG0005H9 MDL No.:MFCD09832387
MF:C7H7F2NO MW:159.1334
|
Benzenesulfonyl chloride, 2,3,6-trifluoro-
Catalog No.:AG0005H8 MDL No.:MFCD09832391
MF:C6H2ClF3O2S MW:230.5921
|
Benzoyl chloride, 3-ethoxy-2,4-difluoro-
Catalog No.:AG0005H7 MDL No.:MFCD09258724
MF:C9H7ClF2O2 MW:220.6005
|
1H-Pyrazol-5-amine, 1-(2,3-dichlorophenyl)-3-(1,1-dimethylethyl)-
Catalog No.:AG0005H6 MDL No.:MFCD04115079
MF:C13H15Cl2N3 MW:284.1843
|
1H-Pyrazol-5-amine, 1-(2,4-dichlorophenyl)-3-(1,1-dimethylethyl)-
Catalog No.:AG0005H5 MDL No.:MFCD04115080
MF:C13H15Cl2N3 MW:284.1843
|
1H-Pyrazol-5-amine, 1-(2,6-dichlorophenyl)-3-(1,1-dimethylethyl)-
Catalog No.:AG0005H4 MDL No.:MFCD04115081
MF:C13H15Cl2N3 MW:284.1843
|
1H-Pyrazol-5-amine, 1-(2,5-dichlorophenyl)-3-(1,1-dimethylethyl)-
Catalog No.:AG0005H3 MDL No.:MFCD04115089
MF:C13H15Cl2N3 MW:284.1843
|
1H-Pyrazole-3-carboxylic acid, 5-[4-(methylthio)phenyl]-1-[4-(trifluoromethyl)phenyl]-
Catalog No.:AG0005H2 MDL No.:MFCD04115084
MF:C18H13F3N2O2S MW:378.3682
|
1H-Pyrazole-3-carboxylic acid, 1-cyclohexyl-5-[4-(methylthio)phenyl]-
Catalog No.:AG0005H1 MDL No.:MFCD04115102
MF:C17H20N2O2S MW:316.4179
|
1H-Pyrazole-4-carboxylic acid, 5-[[(1,1-dimethylethoxy)carbonyl]amino]-1-(4-fluorophenyl)-
Catalog No.:AG0005H0 MDL No.:MFCD04115103
MF:C15H16FN3O4 MW:321.3036
|
1H-Pyrazole-4-carboxylic acid, 1-(4-fluorophenyl)-5-[[(phenylmethoxy)carbonyl]amino]-
Catalog No.:AG0005GZ MDL No.:MFCD04115104
MF:C18H14FN3O4 MW:355.3199
|
1H-Pyrazol-5-amine, 3-(3-bromophenyl)-1-methyl-
Catalog No.:AG0005GY MDL No.:MFCD06738293
MF:C10H10BrN3 MW:252.1105
|
1H-Pyrazol-5-amine, 3-(3-fluorophenyl)-1-methyl-
Catalog No.:AG0005IB MDL No.:MFCD06738294
MF:C10H10FN3 MW:191.2049
|
1H-Pyrazol-5-amine, 3-(4-bromophenyl)-1-(1-methylethyl)-
Catalog No.:AG0005IA MDL No.:MFCD06738300
MF:C12H14BrN3 MW:280.1637
|
1H-Pyrazole-4-carbothioamide
Catalog No.:AG0005I9 MDL No.:MFCD06738945
MF:C4H5N3S MW:127.1676
|
1H-Pyrazol-5-amine, 3-(4-iodophenyl)-1-phenyl-
Catalog No.:AG0005I8 MDL No.:MFCD06738765
MF:C15H12IN3 MW:361.1803
|
1H-Pyrazol-5-amine, 3-(3-iodophenyl)-1-phenyl-
Catalog No.:AG0005I7 MDL No.:MFCD06738298
MF:C15H12IN3 MW:361.1803
|
1H-Pyrazol-5-amine, 1-phenyl-3-propyl-
Catalog No.:AG0005I6 MDL No.:MFCD06738761
MF:C12H15N3 MW:201.2676
|
1H-Pyrazol-5-amine, 3-ethyl-1-phenyl-
Catalog No.:AG0005I5 MDL No.:MFCD02255835
MF:C11H13N3 MW:187.2410
|
1H-Pyrazol-5-amine, 3-(4-iodophenyl)-1-(1-methylethyl)-
Catalog No.:AG0005I4 MDL No.:MFCD06738299
MF:C12H14IN3 MW:327.1641
|
2-Naphthalenesulfonic acid, 1,2,3,4-tetrahydro-2-hydroxy-6-methoxy-, sodium salt (1:1)
Catalog No.:AG0005I3 MDL No.:MFCD05663953
MF:C11H13NaO5S MW:280.2727
|
2H-Pyran-4-carboxamide, tetrahydro-N-methyl-
Catalog No.:AG0005I2 MDL No.:MFCD09997712
MF:C7H13NO2 MW:143.1836
|
Benzenepropanoic acid, 4-[[(1,1-dimethylethoxy)carbonyl]amino]-β-oxo-, ethyl ester
Catalog No.:AG0005I1 MDL No.:MFCD09997714
MF:C16H21NO5 MW:307.3416
|
Benzenepropanoic acid, 2-[[(1,1-dimethylethoxy)carbonyl]amino]-β-oxo-, ethyl ester
Catalog No.:AG0005I0 MDL No.:MFCD09997715
MF:C16H21NO5 MW:307.3416
|
Benzenepropanoic acid, 3-[[(1,1-dimethylethoxy)carbonyl]amino]-β-oxo-, ethyl ester
Catalog No.:AG0005HZ MDL No.:MFCD09997716
MF:C16H21NO5 MW:307.3416
|
1-Piperidinecarboxylic acid, 4-[3-(3-bromophenyl)-1,3-dioxopropyl]-, 1,1-dimethylethyl ester
Catalog No.:AG0005HY MDL No.:MFCD09997717
MF:C19H24BrNO4 MW:410.3022
|
1-Piperidinecarboxylic acid, 4-[3-(4-bromophenyl)-1,3-dioxopropyl]-, 1,1-dimethylethyl ester
Catalog No.:AG0005HX MDL No.:MFCD09997718
MF:C19H24BrNO4 MW:410.3022
|
1-Piperidinecarboxylic acid, 4-[3-(4-chlorophenyl)-1,3-dioxopropyl]-, 1,1-dimethylethyl ester
Catalog No.:AG0005HW MDL No.:MFCD09997719
MF:C19H24ClNO4 MW:365.8512
|
1-Piperidinecarboxylic acid, 4-[3-(3-chlorophenyl)-1,3-dioxopropyl]-, 1,1-dimethylethyl ester
Catalog No.:AG0005HV MDL No.:MFCD09997720
MF:C19H24ClNO4 MW:365.8512
|
2-Thiazolecarbonitrile, 4-bromo-
Catalog No.:AG0005HU MDL No.:MFCD09607690
MF:C4HBrN2S MW:189.0331
|
1-Piperidinecarboxylic acid, 4-(1,3-dioxo-3-phenylpropyl)-, 1,1-dimethylethyl ester
Catalog No.:AG0005HT MDL No.:MFCD09997722
MF:C19H25NO4 MW:331.4061
|
Ethanone, 1-[4-(aminomethyl)phenyl]-2-(4-methoxyphenyl)-
Catalog No.:AG0005HS MDL No.:MFCD09997752
MF:C16H17NO2 MW:255.3117
|
3-Thiopheneethanamine, α-(trifluoromethyl)-
Catalog No.:AG0005HR MDL No.:MFCD09997754
MF:C7H8F3NS MW:195.2053
|
4-Piperidinol, 1-(4-bromo-2-thiazolyl)-
Catalog No.:AG0005HQ MDL No.:MFCD09607693
MF:C8H11BrN2OS MW:263.1547
|
Carbamic acid, N-[[4-[2-(4-chlorophenyl)acetyl]phenyl]methyl]-, 1,1-dimethylethyl ester
Catalog No.:AG0005HP MDL No.:MFCD09997756
MF:C20H22ClNO3 MW:359.8466
|
Morpholine, 4-(4-bromo-2-thiazolyl)-
Catalog No.:AG0005HO MDL No.:MFCD09607696
MF:C7H9BrN2OS MW:249.1282
|
Ethanone, 1-[4-(aminomethyl)phenyl]-2-(4-chlorophenyl)-
Catalog No.:AG0005HN MDL No.:MFCD09997757
MF:C15H14ClNO MW:259.7308
|
Carbamic acid, N-[[3-[2-(4-chlorophenyl)acetyl]phenyl]methyl]-, 1,1-dimethylethyl ester
Catalog No.:AG0005J0 MDL No.:MFCD09997759
MF:C20H22ClNO3 MW:359.8466
|
4-Piperidinol, 1-(6-bromo-2-pyridinyl)-
Catalog No.:AG0005IZ MDL No.:MFCD09607698
MF:C10H13BrN2O MW:257.1270
|
Ethanone, 1-[3-(aminomethyl)phenyl]-2-(4-chlorophenyl)-
Catalog No.:AG0005IY MDL No.:MFCD09997760
MF:C15H14ClNO MW:259.7308
|
Carbamic acid, N-[[4-(2-phenylacetyl)phenyl]methyl]-, 1,1-dimethylethyl ester
Catalog No.:AG0005IX MDL No.:MFCD09997764
MF:C20H23NO3 MW:325.4015
|
Ethanone, 1-[3-(aminomethyl)phenyl]-2-phenyl-
Catalog No.:AG0005IW MDL No.:MFCD09997765
MF:C15H15NO MW:225.2857
|
Morpholine, 4-(5-chloro-2-pyrazinyl)-
Catalog No.:AG0005IV MDL No.:
MF:C8H10ClN3O MW:199.6375
|
Carbamic acid, N-[[4-[2-(4-fluorophenyl)acetyl]phenyl]methyl]-, 1,1-dimethylethyl ester
Catalog No.:AG0005IU MDL No.:MFCD09997767
MF:C20H22FNO3 MW:343.3920
|
Ethanone, 1-[4-(aminomethyl)phenyl]-2-(4-fluorophenyl)-
Catalog No.:AG0005IT MDL No.:MFCD09997768
MF:C15H14FNO MW:243.2762
|
Carbamic acid, N-[[3-[2-(4-fluorophenyl)acetyl]phenyl]methyl]-, 1,1-dimethylethyl ester
Catalog No.:AG0005IS MDL No.:MFCD09997770
MF:C20H22FNO3 MW:343.3920
|
Ethanone, 1-[3-(aminomethyl)phenyl]-2-(4-fluorophenyl)-
Catalog No.:AG0005IR MDL No.:MFCD09997771
MF:C15H14FNO MW:243.2762
|
Carbamic acid, N-[[4-[2-(4-methylphenyl)acetyl]phenyl]methyl]-, 1,1-dimethylethyl ester
Catalog No.:AG0005IQ MDL No.:MFCD09997773
MF:C21H25NO3 MW:339.4281
|
Ethanone, 1-[4-(aminomethyl)phenyl]-2-(4-methylphenyl)-
Catalog No.:AG0005IP MDL No.:MFCD09997774
MF:C16H17NO MW:239.3123
|
Carbamic acid, N-[[3-[2-(4-methylphenyl)acetyl]phenyl]methyl]-, 1,1-dimethylethyl ester
Catalog No.:AG0005IO MDL No.:MFCD09997776
MF:C21H25NO3 MW:339.4281
|
Carbamic acid, N-[[4-[2-(4-methoxyphenyl)acetyl]phenyl]methyl]-, 1,1-dimethylethyl ester
Catalog No.:AG0005IN MDL No.:MFCD09997777
MF:C21H25NO4 MW:355.4275
|
Carbamic acid, N-(2-amino-6-bromophenyl)-, 1,1-dimethylethyl ester
Catalog No.:AG0005IM MDL No.:MFCD09997784
MF:C11H15BrN2O2 MW:287.1530
|
1H-Indazole, 3-chloro-1-(3-pyridinylmethyl)-
Catalog No.:AG0005IL MDL No.:MFCD09997802
MF:C13H10ClN3 MW:243.6916
|
Pyrimidine, 4,6-dichloro-2-(1-piperazinyl)-
Catalog No.:AG0005IK MDL No.:
MF:C8H10Cl2N4 MW:233.0978
|
1H-Indazole, 3-chloro-1-(2-pyridinylmethyl)-
Catalog No.:AG0005IJ MDL No.:MFCD09997803
MF:C13H10ClN3 MW:243.6916
|
1H-Indazole, 3-bromo-5,6-difluoro-
Catalog No.:AG0005II MDL No.:MFCD09997805
MF:C7H3BrF2N2 MW:233.0129
|
Oxazolo[4,5-c]pyridine, 2-(4-bromophenyl)-4,5,6,7-tetrahydro-5-methyl-
Catalog No.:AG0005IH MDL No.:MFCD09997824
MF:C13H13BrN2O MW:293.1591
|
Oxazolo[4,5-c]pyridine, 4,5,6,7-tetrahydro-2,5-dimethyl-
Catalog No.:AG0005IG MDL No.:MFCD09997826
MF:C8H12N2O MW:152.1937
|
4-Piperidinamine, 3-methyl-1-(1-methylethyl)-
Catalog No.:AG0005IF MDL No.:MFCD09997859
MF:C9H20N2 MW:156.2685
|
2-Pyridinamine, 6-methoxy-3-nitro-5-phenyl-
Catalog No.:AG0005IE MDL No.:MFCD09997887
MF:C12H11N3O3 MW:245.2340
|
2-Pyridinamine, 5-bromo-6-methoxy-3-nitro-
Catalog No.:AG0005ID MDL No.:MFCD09997888
MF:C6H6BrN3O3 MW:248.0341
|
Carbamic acid, N-(3-amino-6-chloro-2-pyridinyl)-, 1,1-dimethylethyl ester
Catalog No.:AG0005IC MDL No.:MFCD09997889
MF:C10H14ClN3O2 MW:243.6901
|
Carbamic acid, N-(6-chloro-3-nitro-2-pyridinyl)-, 1,1-dimethylethyl ester
Catalog No.:AG0005JP MDL No.:MFCD09997890
MF:C10H12ClN3O4 MW:273.6730
|
Imidazo[1,2-a]pyrazine-2-carboxaldehyde
Catalog No.:AG0005JO MDL No.:MFCD09995736
MF:C7H5N3O MW:147.1341
|
4H-Pyrrolo[3,4-c]quinolin-4-one, 1,2,3,3a,5,9b-hexahydro-2-(phenylmethyl)-
Catalog No.:AG0005JN MDL No.:MFCD09997913
MF:C18H18N2O MW:278.3483
|
1H-Pyrazole-4-carboxylic acid, 3-(1,1-dimethylethyl)-, methyl ester
Catalog No.:AG0005JM MDL No.:MFCD00829900
MF:C9H14N2O2 MW:182.2197
|
Pyridine, 5-bromo-2-chloro-3-(chloromethyl)-
Catalog No.:AG0005JL MDL No.:MFCD09865020
MF:C6H4BrCl2N MW:240.9127
|
3-Piperidinecarboxylic acid, 1-[[[(1,1-dimethylethoxy)carbonyl](phenylmethyl)amino]sulfonyl]-
Catalog No.:AG0005JK MDL No.:MFCD09972238
MF:C18H26N2O6S MW:398.4738
|
1-Piperazinecarboxylic acid, 4-(3-methoxy-4-nitrophenyl)-, 1,1-dimethylethyl ester
Catalog No.:AG0005JJ MDL No.:MFCD09972251
MF:C16H23N3O5 MW:337.3709
|
3-Piperidinecarboxylic acid, 1-[[(2-bromoethyl)[(1,1-dimethylethoxy)carbonyl]amino]sulfonyl]-, ethyl ester
Catalog No.:AG0005JI MDL No.:MFCD09972257
MF:C15H27BrN2O6S MW:443.3537
|
Methanone, (5-bromo-3-pyridinyl)-1-piperazinyl-
Catalog No.:AG0005JH MDL No.:MFCD09972258
MF:C10H12BrN3O MW:270.1258
|
3-Pyridinecarboxylic acid, 5-bromo-2-(4-morpholinyl)-, methyl ester
Catalog No.:AG0005JG MDL No.:MFCD09972266
MF:C11H13BrN2O3 MW:301.1365
|
3-Pyridinecarboxylic acid, 5-bromo-2-(4-morpholinyl)-
Catalog No.:AG0005JF MDL No.:MFCD09972268
MF:C10H11BrN2O3 MW:287.1099
|
2H-3,1-Benzoxazin-2-one, 6-bromo-1,4-dihydro-
Catalog No.:AG0005JE MDL No.:MFCD09972273
MF:C8H6BrNO2 MW:228.0427
|
1H-Pyrazole-4-carboxylic acid, 3-(4-fluorophenyl)-, methyl ester
Catalog No.:AG0005JD MDL No.:
MF:C11H9FN2O2 MW:220.1998
|
1H-Pyrazole-4-methanamine, 5-amino-1-(4-fluorophenyl)-
Catalog No.:AG0005JC MDL No.:MFCD06212838
MF:C10H11FN4 MW:206.2195
|
Benzenemethanamine, 4-(1H-pyrazol-3-yl)-
Catalog No.:AG0005JB MDL No.:MFCD11200994
MF:C10H11N3 MW:173.2144
|
2-Propenoic acid, 3-[1,3-dimethyl-5-(4-morpholinyl)-1H-pyrazol-4-yl]-
Catalog No.:AG0005JA MDL No.:
MF:C12H17N3O3 MW:251.2817
|
1-Piperidinecarboxylic acid, 2-cyano-, phenylmethyl ester
Catalog No.:AG0005J9 MDL No.:MFCD08704536
MF:C14H16N2O2 MW:244.2890
|
3-Quinolinecarbonitrile, 4-chloro-7-hydroxy-
Catalog No.:AG0005J8 MDL No.:
MF:C10H5ClN2O MW:204.6125
|
Pyrimidine, 5-bromo-2-(2-bromo-4-methylphenoxy)-
Catalog No.:AG0005J7 MDL No.:
MF:C11H8Br2N2O MW:344.0020
|
Pyrimidine, 5-bromo-2-(4-pyridinyloxy)-
Catalog No.:AG0005J6 MDL No.:
MF:C9H6BrN3O MW:252.0674
|
1,2,4-Triazolo[4,3-a]pyrimidine-3-carboxylic acid, 5,7-dimethyl-, ethyl ester
Catalog No.:AG0005J5 MDL No.:
MF:C10H12N4O2 MW:220.2279
|
2-Thiophenecarbonitrile, 3-amino-5-bromo-
Catalog No.:AG0005J4 MDL No.:MFCD09991574
MF:C5H3BrN2S MW:203.0597
|
2-Thiophenecarbonitrile, 3-amino-5-ethyl-
Catalog No.:AG0005J3 MDL No.:
MF:C7H8N2S MW:152.2168
|
Benzamide, 2-amino-3-fluoro-N-methyl-
Catalog No.:AG0005J2 MDL No.:
MF:C8H9FN2O MW:168.1683
|
2-Propenoic acid, 2-ethoxy-3-[4-(phenylmethoxy)phenyl]-
Catalog No.:AG0005J1 MDL No.:
MF:C18H18O4 MW:298.3331
|
1,3,8-Triazaspiro[4.5]dec-1-en-4-one, 8-(phenylmethyl)-
Catalog No.:AG0005KE MDL No.:
MF:C14H17N3O MW:243.3043
|
Benzeneacetic acid, α-(3-bromopropyl)-4-chloro-
Catalog No.:AG0005KD MDL No.:MFCD09991598
MF:C11H12BrClO2 MW:291.5688
|
3,6-Diazabicyclo[3.2.0]heptane-3-carboxylic acid, 1,1-dimethylethyl ester
Catalog No.:AG0005KC MDL No.:MFCD09991607
MF:C10H18N2O2 MW:198.2621
|
1-Piperidinecarboxylic acid, 4-[3-methoxy-3-oxo-2-[[(phenylmethoxy)carbonyl]amino]-1-propen-1-yl]-, 1,1-dimethylethyl ester
Catalog No.:AG0005KB MDL No.:
MF:C22H30N2O6 MW:418.4834
|
1-Piperidinecarboxylic acid, 3-[3-methoxy-3-oxo-2-[[(phenylmethoxy)carbonyl]amino]-1-propen-1-yl]-, 1,1-dimethylethyl ester
Catalog No.:AG0005KA MDL No.:
MF:C22H30N2O6 MW:418.4834
|
Carbamic acid, N-(4,6-dichloro-2-pyridinyl)-, 1,1-dimethylethyl ester
Catalog No.:AG0005K9 MDL No.:MFCD09991634
MF:C10H12Cl2N2O2 MW:263.1205
|
Benzenepropanoic acid, 4-chloro-β-[[(1,1-dimethylethoxy)carbonyl]amino]-, phenylmethyl ester
Catalog No.:AG0005K8 MDL No.:
MF:C21H24ClNO4 MW:389.8726
|
1-Pyrrolidinecarboxylic acid, 3-amino-4-(hydroxymethyl)-, phenylmethyl ester
Catalog No.:AG0005K7 MDL No.:MFCD09991641
MF:C13H18N2O3 MW:250.2936
|
Propanamide, N-(2,3-dimethyl-4-nitrophenyl)-2,2-dimethyl-
Catalog No.:AG0005K6 MDL No.:
MF:C13H18N2O3 MW:250.2936
|
Phosphonic acid, P,P'-9,10-anthracenediylbis-, P,P,P',P'-tetraethyl ester
Catalog No.:AG0005K5 MDL No.:MFCD09991665
MF:C22H28O6P2 MW:450.4016
|
Propanamide, N-(2,3-dimethyl-6-nitrophenyl)-2,2-dimethyl-
Catalog No.:AG0005K4 MDL No.:
MF:C13H18N2O3 MW:250.2936
|
Benzenebutanol, 2,4-dinitro-
Catalog No.:AG0005K3 MDL No.:
MF:C10H12N2O5 MW:240.2127
|
2-Propenoic acid, 4-(2,4-dinitrophenyl)butyl ester
Catalog No.:AG0005K2 MDL No.:
MF:C13H14N2O6 MW:294.2601
|
2-Propenamide, N-[2-(3,5-dinitrophenyl)ethyl]-
Catalog No.:AG0005K1 MDL No.:
MF:C11H11N3O5 MW:265.2221
|
1-Piperidineacetic acid, α-(4-fluorophenyl)-4-oxo-, ethyl ester
Catalog No.:AG0005K0 MDL No.:
MF:C15H18FNO3 MW:279.3067
|
Benzeneacetic acid, α-acetyl-4-fluoro-2-nitro-, ethyl ester
Catalog No.:AG0005JZ MDL No.:
MF:C12H12FNO5 MW:269.2258
|
Benzenemethanol, 3-methoxy-4-(4-methyl-1H-imidazol-1-yl)-
Catalog No.:AG0005JY MDL No.:MFCD09991721
MF:C12H14N2O2 MW:218.2518
|
Cyclopropanecarboxamide, N-(methoxymethyl)-1-(trifluoromethyl)-
Catalog No.:AG0005JX MDL No.:
MF:C7H10F3NO2 MW:197.1550
|
Carbamic acid, N-(1-methyl-3-azetidinyl)-, 1,1-dimethylethyl ester
Catalog No.:AG0005JW MDL No.:
MF:C9H18N2O2 MW:186.2514
|
Benzenepropanoic acid, 3-bromo-β-[(2-phenylacetyl)amino]-
Catalog No.:AG0005JV MDL No.:
MF:C17H16BrNO3 MW:362.2178
|
Benzoic acid, 2,3,5,6-tetrafluoro-4-[(6-hydroxyhexyl)oxy]-
Catalog No.:AG0005JU MDL No.:
MF:C13H14F4O4 MW:310.2415
|
Benzoic acid, 2,3,5,6-tetrafluoro-4-[(8-hydroxyoctyl)oxy]-
Catalog No.:AG0005JT MDL No.:
MF:C15H18F4O4 MW:338.2946
|
1H-Pyrrole-3-acetic acid, 1-[(4-methylphenyl)sulfonyl]-
Catalog No.:AG0005JS MDL No.:
MF:C13H13NO4S MW:279.3116
|
2H-1,4-Benzoxazine-6-sulfonyl chloride, 4-acetyl-3,4-dihydro-
Catalog No.:AG0005JR MDL No.:MFCD09972061
MF:C10H10ClNO4S MW:275.7087
|
Pyridazine, 3-ethynyl-
Catalog No.:AG0005JQ MDL No.:MFCD16988473
MF:C6H4N2 MW:104.1094
|
1H-Indazole-4-carboxylic acid, 1-acetyl-
Catalog No.:AG0005KK MDL No.:
MF:C10H8N2O3 MW:204.1821
|
Pyridine, 2,5-difluoro-4-iodo-
Catalog No.:AG0005KJ MDL No.:MFCD11040606
MF:C5H2F2IN MW:240.9774
|
Pyridine, 4-bromo-3-chloro-2-fluoro-
Catalog No.:AG0005KI MDL No.:MFCD11040607
MF:C5H2BrClFN MW:210.4315
|
1,6-NAPHTHYRIDINE-3-CARBOXYLIC ACID
Catalog No.:AG0005KH MDL No.:MFCD07366468
MF:C9H6N2O2 MW:174.1561
|
2-Thiophenecarboxylic acid, 5-(1H-pyrazol-4-yl)-
Catalog No.:AG0005KG MDL No.:MFCD08056305
MF:C8H6N2O2S MW:194.2104
|
1-Piperidinecarboxylic acid, 3-mercapto-, 1,1-dimethylethyl ester
Catalog No.:AG0005KF MDL No.:MFCD10566038
MF:C10H19NO2S MW:217.3284
|
Cyclohexanone, 2,6-dimethyl-2-phenyl-
Catalog No.:AG0005L3 MDL No.:
MF:C14H18O MW:202.2921
|
Benzene, 1-bromo-2-[(2-methyl-2-propen-1-yl)oxy]-
Catalog No.:AG0005L2 MDL No.:
MF:C10H11BrO MW:227.0977
|
Benzofuran, 7-chloro-2,3-dihydro-2,2-dimethyl-
Catalog No.:AG0005L1 MDL No.:MFCD11858104
MF:C10H11ClO MW:182.6467
|
Benzeneethanamine, N-[(3-ethoxy-4-methoxyphenyl)methyl]-
Catalog No.:AG0005KT MDL No.:
MF:C18H23NO2 MW:285.3807
|
Benzenemethanol, α-[4-(4-amino-2-methoxyphenoxy)butyl]-
Catalog No.:AG0005KS MDL No.:
MF:C18H23NO3 MW:301.3801
|
1H-Indole-3-carboxylic acid, 1-cyclohexyl-5-hydroxy-2-methyl-, ethyl ester
Catalog No.:AG0005KR MDL No.:MFCD00408072
MF:C18H23NO3 MW:301.3801
|
1H-Pyrazol-5-amine, 1,4-diphenyl-3-propyl-
Catalog No.:AG0005KQ MDL No.:
MF:C18H19N3 MW:277.3636
|
Benzene, 1,1'-(1,6-hexanediyl)bis[4-bromo-
Catalog No.:AG0005KP MDL No.:
MF:C18H20Br2 MW:396.1594
|
Acetamide, 2-(diethylamino)-N,N-diphenyl-
Catalog No.:AG0005KO MDL No.:
MF:C18H22N2O MW:282.3801
|
1,4-Butanediol, 2,3-bis(phenylmethyl)-
Catalog No.:AG0005KN MDL No.:
MF:C18H22O2 MW:270.3661
|
Benzoic acid, 2-[4-(2-methylpropyl)benzoyl]-
Catalog No.:AG0005KM MDL No.:
MF:C18H18O3 MW:282.3337
|
Benzenamine, 4-(4,5-dihydro-1,3-diphenyl-1H-pyrazol-5-yl)-
Catalog No.:AG0005L0 MDL No.:
MF:C21H19N3 MW:313.3957
|
Acetamide, N-[4-(4,5-dihydro-1,3-diphenyl-1H-pyrazol-5-yl)phenyl]-
Catalog No.:AG0005KZ MDL No.:
MF:C23H21N3O MW:355.4323
|
3H-1,2,3-Triazolo[4,5-d]pyrimidine, 7-methyl-
Catalog No.:AG0005KY MDL No.:
MF:C5H5N5 MW:135.1267
|
3H-1,2,3-Triazolo[4,5-d]pyrimidin-5-amine
Catalog No.:AG0005KX MDL No.:MFCD20616954
MF:C4H4N6 MW:136.1148
|
9H-Purin-2-amine, 8-(trifluoromethyl)-
Catalog No.:AG0005KW MDL No.:MFCD08275968
MF:C6H4F3N5 MW:203.1247
|
9H-Purine, 8-(methylsulfonyl)-
Catalog No.:AG0005KV MDL No.:
MF:C6H6N4O2S MW:198.2024
|
9H-Purine, 2,8-bis(methylthio)-
Catalog No.:AG0005KU MDL No.:
MF:C7H8N4S2 MW:212.2952
|
Undecanoic acid, 11-(hexylsulfinyl)-
Catalog No.:AG0005KL MDL No.:
MF:C17H34O3S MW:318.5151
|
Nonane, 1-[2-(2-butoxyethoxy)ethoxy]-
Catalog No.:AG0005LI MDL No.:
MF:C17H36O3 MW:288.4659
|
Nonane, 1-[2-[2-(2-methylpropoxy)ethoxy]ethoxy]-
Catalog No.:AG0005LH MDL No.:
MF:C17H36O3 MW:288.4659
|
2H-Imidazol-2-one, 1-(diphenylmethyl)-3-ethyl-1,3-dihydro-
Catalog No.:AG0005LG MDL No.:
MF:C18H18N2O MW:278.3483
|
Ethanone, 2-(4-morpholinyl)-1-(10H-phenoxazin-10-yl)-
Catalog No.:AG0005LF MDL No.:
MF:C18H18N2O3 MW:310.3471
|
Uridine, 5-methyl-5'-O-(triphenylmethyl)-
Catalog No.:AG0005LE MDL No.:
MF:C29H28N2O6 MW:500.5424
|
4-Quinolinecarboxylic acid, 7-hydroxy-
Catalog No.:AG0005L5 MDL No.:MFCD11847889
MF:C10H7NO3 MW:189.1675
|
8-Isoquinolinecarboxylic acid, 2,3-dihydro-3-oxo-, methyl ester
Catalog No.:AG0005L4 MDL No.:
MF:C11H9NO3 MW:203.1941
|
Benzamide, N,N'-(2-hydroxy-1,3-propanediyl)bis-
Catalog No.:AG0005LD MDL No.:
MF:C17H18N2O3 MW:298.3364
|
Benzothiazole, 2-(4'-chloro[1,1'-biphenyl]-4-yl)-
Catalog No.:AG0005LC MDL No.:
MF:C19H12ClNS MW:321.8233
|
1,1':3',1''-Terphenyl, 4-phenoxy- (9CI)
Catalog No.:AG0005LB MDL No.:
MF:C24H18O MW:322.3991
|
Piperidine, 4-[(4-chlorophenyl)thio]-, hydrochloride (1:1)
Catalog No.:AG0005LA MDL No.:MFCD03840148
MF:C11H15Cl2NS MW:264.2145
|
Piperidine, 4-(phenylthio)-, hydrochloride (1:1)
Catalog No.:AG0005L9 MDL No.:MFCD03840144
MF:C11H16ClNS MW:229.7694
|
Piperidine, 4-[(4-fluorophenyl)thio]-
Catalog No.:AG0005L8 MDL No.:MFCD16076688
MF:C11H14FNS MW:211.2990
|
Piperidine, 4-[(4-fluorophenyl)thio]-, hydrochloride (1:1)
Catalog No.:AG0005L7 MDL No.:MFCD04117760
MF:C11H15ClFNS MW:247.7599
|
3H-Pyrazol-3-one, 1,2-dihydro-4-phenyl-2-(2-pyridinyl)-
Catalog No.:AG0005L6 MDL No.:
MF:C14H11N3O MW:237.2566
|
Benzoic acid, triethylgermyl ester
Catalog No.:AG0005LS MDL No.:
MF:C13H20GeO2 MW:280.9367
|
Phosphonic acid, P-(2-phenylethenyl)-, diethyl ester
Catalog No.:AG0005LR MDL No.:
MF:C12H17O3P MW:240.2353
|
Pyrrolidinium, 1,1-dimethyl-2-[[2-(trimethylammonio)ethoxy]carbonyl]-, iodide (1:2)
Catalog No.:AG0005LQ MDL No.:
MF:C12H26I2N2O2 MW:484.1560
|
1H-Pyrazol-3-amine, 2,5-dihydro-1-[(4-methylphenyl)sulfonyl]-
Catalog No.:AG0005LP MDL No.:
MF:C10H13N3O2S MW:239.2941
|
1H,3H-Naphtho[1,8-cd]pyran-1-one, 6-(chloromethyl)-
Catalog No.:AG0005LO MDL No.:MFCD00683109
MF:C13H9ClO2 MW:232.6624
|
1H-Purine-2,6-dione, 3,7-dihydro-7-methoxy-1,3,8-trimethyl-
Catalog No.:AG0005LN MDL No.:
MF:C9H12N4O3 MW:224.2166
|
3-Pyrazolidinone, 5-methoxy-4,4-dimethyl-1-phenyl-
Catalog No.:AG0005LM MDL No.:
MF:C12H16N2O2 MW:220.2676
|
2,3-Naphthalenedicarbonitrile, 1,4-dihydro-1,4-dioxo-
Catalog No.:AG0005LL MDL No.:
MF:C12H4N2O2 MW:208.1724
|
2,3-Naphthalenedicarbonitrile, 1,4-dihydroxy-
Catalog No.:AG0005LK MDL No.:MFCD00192049
MF:C12H6N2O2 MW:210.1882
|
5H-Thiazolo[3,2-a]quinazolin-5-one, 2-(bromomethyl)-1,2-dihydro-
Catalog No.:AG0005LJ MDL No.:
MF:C11H9BrN2OS MW:297.1710
|
Pyrimidine, 5-iodo-2-methoxy-
Catalog No.:AG0005M6 MDL No.:MFCD18412677
MF:C5H5IN2O MW:236.0105
|
Phosphorous acid, bis(2,2,2-trifluoroethyl) trimethylsilyl ester
Catalog No.:AG0005M5 MDL No.:
MF:C7H13F6O3PSi MW:318.2260
|
2-Undecanol, 11-fluoro-
Catalog No.:AG0005M4 MDL No.:
MF:C11H23FO MW:190.2981
|
Pentanedioic acid, 2,2,3-trimethyl-, 1,5-dimethyl ester
Catalog No.:AG0005M3 MDL No.:
MF:C10H18O4 MW:202.2475
|
Phosphonic acid, P-(1-amino-1,2-dimethylpropyl)-
Catalog No.:AG0005M2 MDL No.:
MF:C5H14NO3P MW:167.1433
|
3-Isoxazolecarboxylic acid, 5-(1-methylethyl)-, methyl ester
Catalog No.:AG0005LY MDL No.:MFCD09701707
MF:C8H11NO3 MW:169.1778
|
Benzene, 5-(2,6-dimethylphenoxy)-2-methoxy-1,3-dimethyl-
Catalog No.:AG0005M8 MDL No.:
MF:C17H20O2 MW:256.3395
|
1,2-Dioxolane, 3-(4-methoxyphenyl)-4-methylene-3-phenyl-
Catalog No.:AG0005M1 MDL No.:
MF:C17H16O3 MW:268.3071
|
Pyrido[2,3-d]pyrimidine-6-carbonitrile, 2,4-diamino-5-methyl-
Catalog No.:AG0005M0 MDL No.:
MF:C9H8N6 MW:200.2000
|
Pyrido[2,3-d]pyrimidine-6-carboxaldehyde, 2,4-diamino-5-methyl-
Catalog No.:AG0005LZ MDL No.:
MF:C9H9N5O MW:203.2007
|
6-Aminopyrazolo[1,5-a]pyrimidine
Catalog No.:AG0005LX MDL No.:MFCD09701813
MF:C6H6N4 MW:134.1386
|
3-Quinolinecarboxylic acid, 4-amino-8-methoxy-
Catalog No.:AG0005LW MDL No.:MFCD11058008
MF:C11H10N2O3 MW:218.2087
|
Isoxazole, 3-(chloromethyl)-5-(1-methylethyl)-
Catalog No.:AG0005LV MDL No.:MFCD09859196
MF:C7H10ClNO MW:159.6134
|
3-Quinolinecarboxylic acid, 6-amino-4-hydroxy-
Catalog No.:AG0005LU MDL No.:MFCD11058007
MF:C10H8N2O3 MW:204.1821
|
1H-Pyrazolo[3,4-b]pyridine-4-carboxylic acid, 6,7-dihydro-3-methyl-6-oxo-, ethyl ester
Catalog No.:AG0005LT MDL No.:
MF:C10H11N3O3 MW:221.2126
|